Sidney Smith, M.D
Professor, Department of Medicine | UNC-Chapel Hill
Chapel Hill, NC, UNITED STATES
Dr. Sidney Smith is an expert on interventional cardiology, coronary angioplasty, coronary heart disease, and preventive cardiology.
Biography
Sidney C. Smith Jr., MD, is Professor of Medicine and Director of the Center for Cardiovascular Science and Medicine at the University of North Carolina at Chapel Hill. Dr. Smith received his medical degree from Yale University. He completed a residency in internal medicine and a fellowship in cardiology at Harvard Medical School/Peter Bent Brigham Hospital in Boston, Massachusetts.
Dr. Smith served as national President of the American Heart Association (AHA) (1995-1996) and currently serves as Chair of the American College of Cardiology (ACC)/AHA Task Force on Practice Guidelines and Chair of the ACC/AHA Committee to Revise the Percutaneus Coronary Intervention (PCI) Guidelines. Dr. Smith is also Chairman of the Scientific Advisory Board of the World Heart Federation. He is a primary author of the Principles for National and Regional Guidelines on Cardiovascular Disease Prevention and is active at the international level in the development and implementation of programs to prevent cardiovascular disease.
Dr. Smith's early research focus involved lipoprotein abnormalities, reperfusion therapies for acute myocardial infarction, and medical management of unstable angina pectoris. Currently, his interests center on the evaluation of primary and secondary prevention efforts in the treatment of cardiovascular disease and the use of guidelines and performance measures to assess cardiovascular outcomes in health care systems.
Dr. Smith is a member of several editorial boards including Circulation, the Journal of Interventional Cardiology, ACCEL, the Journal of the American College of Cardiology, and the American Heart Journal. He is the author of numerous articles and book chapters and presents regularly at scientific meetings. He has spoken about heart disease and stroke in interviews with CNN, CBS, NBC, and multiple national newspapers. In 1993, Dr. Smith was honored as the American Heart Association’s Physician of the Year. In 1996, Dr. Smith received the Distinguished National Leadership Award and in June of 2000, he received the Gold Heart Award from the AHA. In 2003, he received the Eugene Drake Award for his contributions to cardiovascular medicine. Yearly since 1998, he has been elected to Best Doctors in America. Dr. Smith was honored by the National Heart, Lung, and Blood Institute (NHLBI) with an award of special recognition in 2003.
Industry Expertise (3)
Research
Education/Learning
Medical/Dental Practice
Areas of Expertise (4)
Internal Medicine
Heart Disease
Stroke Prevention
Cardiology
Accomplishments (1)
Joseph Stokes, III, MD Award (professional)
This prestigious award honors those who have made significant contributions in the field of preventive cardiology through research, teaching, clinical activity and leadership.
Education (3)
Harvard Medical School/Peter Bent Brigham Hospital: Fellowship, Cardiology
Harvard Medical School/Peter Bent Brigham Hospital: Residency, Internal Medicine
Yale University: M.D., Medicine 1967
Media Appearances (5)
U.S. Task Force Backs Statins for Those 40 to 75 at Heightened Heart Risk
GetHealthy online
2015-12-21
However, people at that lower level of risk are very likely to also benefit from lifestyle changes such as exercising more or eating a healthier diet, said Dr. Sidney Smith Jr., director of the Center for Cardiovascular Science and Medicine at the University of North Carolina in Chapel Hill. "My concern is, given the choice between taking a pill or changing behavior, people will choose to take a pill and not deal with the lifestyle factors," Smith said. "Taking the pill should not be a substitute for leading a healthy lifestyle, that's for sure."...
AHA: Could PCSK9 Be Suppressed With Twice-Yearly Injection?
MedPage Today online
2015-11-11
"The results are very impressive in terms of the reduction in LDL," Sidney Smith, MD, of the University of North Carolina at Chapel Hill and a past president of the AHA, told MedPage Today. "Right now one of the major problems in lipid lowering is getting patients to adhere to their medication," he added. "So if we can show that there are excellent outcomes with this, comparable to what we see with alternative therapies, and the cost is not prohibitive, I could see this as a very nice option."...
DAPT Risk Score Picks Patients for Extended Tx
MedPage Today online
2015-11-10
"This is exactly what we need," Sidney Smith, MD, of the University of North Carolina at Chapel Hill and a past president of the AHA, told MedPage Today. "The ability to compare the benefit with the risk and decide what might be best for a given patient is extraordinarily useful."...
The Hospital Is No Place for a Heart Attack
The Wall Street Journal online
2015-02-02
“With teams put together in a system, you can have better outcomes,” said Sidney Smith, a cardiologist at University of North Carolina at Chapel Hill who is spearheading the project. “We can save some lives.”...
Sidney C. Smith, Jr. MD, receives the 2013 Joseph Stokes, III, MD Award from the American Society for Preventive Cardiology
UNC Health Care online
2013-03-28
CHAPEL HILL, N.C. -- Sidney C. Smith, Jr, MD, professor of Medicine in the University of North Carolina School of Medicine and clinician in the UNC Center for Heart and Vascular Care, received the 2013 Joseph Stokes, III, MD Award from the American Society for Preventive Cardiology on March 22, 2013. This prestigious award honors those who have made significant contributions in the field of preventive cardiology through research, teaching, clinical activity and leadership. It commemorates Joseph Stokes, III, MD, a cardiologist and epidemiologist who was co-principal investigator of the Framingham Heart Study, a now decades-long study designed to identify the common factors or characteristics that contribute to cardiovascular disease by following its development over a long period of time in a large group.
Articles (5)
Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Disease Risk in Adults: Synopsis of the 2013 American College of Cardiology/American Heart Association Cholesterol Guideline
Annals of Internal Medicine
2014 In November 2013, the American College of Cardiology and American Heart Association (ACC/AHA) released a clinical practice guideline on the treatment of blood cholesterol to reduce cardiovascular risk in adults. This synopsis summarizes the major recommendations.
Multiple Risk Factors for Cardiovascular Disease and Diabetes Mellitus
The American Journal of Medicine
2007 In the past 25 years, obesity and diabetes mellitus have overtaken cigarette smoking, dyslipidemia, and hypertension as risk factors for coronary heart disease. Data from a Centers for Disease Control and Prevention (CDC) survey of 50 states revealed that, in 2000, the prevalence of obesity among US adults was approximately 20%, a 61% increase from the 1991 prevalence rate. Currently, most adults (≥56%) are overweight, approximately 1 in 5 is obese, and 7.3% have diabetes. Overweight and obesity increase the risk for hospitalization and death from cardiovascular disease (CVD) and type 2 diabetes at all levels of risk and independently of other risk factors.
Diagnosis and Management of the Metabolic Syndrome
Circulation
2005 The metabolic syndrome has received increased attention in the past few years. This statement from the American Heart Association (AHA) and the National Heart, Lung, and Blood Institute (NHLBI) is intended to provide up-to-date guidance for professionals on the diagnosis and management of the metabolic syndrome in adults...
Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines
Journal of the American College of Cardiology
2004 The Adult Treatment Panel III (ATP III) of the National Cholesterol Education Program issued an evidence-based set of guidelines on cholesterol management in 2001. Since the publication of ATP III, 5 major clinical trials of statin therapy with clinical end points have ...
Definition of Metabolic Syndrome
NHLBI/AHA Conference Procedings
2004 The National Cholesterol Education Program’s Adult Treatment Panel III report (ATP III)1 identified the metabolic syndrome as a multiplex risk factor for cardiovascular disease (CVD) that is deserving of more clinical attention. The cardiovascular community has responded with heightened awareness and interest. ATP III criteria for metabolic syndrome differ somewhat from those of other organizations. Consequently, the National Heart, Lung, and Blood Institute, in collaboration with the American Heart Association, convened a conference to examine scientific issues related to definition of the metabolic syndrome...
Social